Windlas Biotech Share Price
1136.00+8.90 (+0.79%)
+15.94% past 1 Year
News
Windlas Biotech reports flat Q1 EBITDA, margin declines year on year
Equity
WINDLAS
Windlas Biotech reports flat Q1 profit, revenue rises 19 percent year on year
Equity
WINDLAS
Windlas Biotech - Quaterly Results
Equity
WINDLAS
Windlas Biotech reports Profit after tax of 16.02 Crores, in the March 2026 quarter
Equity
WINDLAS
Windlas Biotech normalises operations after temporary Uttarakhand labour strike disruption
Equity
WINDLAS
Windlas Biotech announces Rs 47 crore share buyback via tender offer route
Equity
WINDLAS
Windlas Biotech: Board Approves Share Buyback At Rs 1,000 Per Share Through Tender Offer
Equity
WINDLAS
Windlas Biotech informs about outcome of postal ballot
Equity
WINDLAS
Windlas Biotech Receives Show Cause Notice, Temporary Suspension of Codeine Cough Syrup Manufacturing.
Equity
WINDLAS
Windlas Biotech - Quaterly Results
Equity
WINDLAS
Windlas Biotech Q3 EBITDA Slightly Down YoY at Rs 24.40 Crores, Margin Contracts to 10.47%.
Equity
WINDLAS
Windlas Biotech Q3FY26 Results: Revenue Up 18% YoY, Net Profit Marginally Down.
Equity
WINDLAS
Windlas Biotech reports Profit after tax of 14.95 Crores, in the December 2025 quarter
Equity
WINDLAS
Windlas Biotech informs about conference call
Equity
WINDLAS
Windlas Biotech reports Profit after tax of 17.80 Crores, in the September 2025 quarter
Equity
WINDLAS
Windlas Biotech informs about analyst meet
Equity
WINDLAS
Windlas Biotech informs about outcome of board meeting
Equity
WINDLAS
Windlas Biotech informs about results presentation
Equity
WINDLAS
Windlas Biotech reports Profit after tax of 17.66 Crores, in the June 2025 quarter
Equity
WINDLAS
Windlas Biotech - Quaterly Results
Equity
WINDLAS